Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$1.6B
47M shares
52-week range
$16.10 – $35.83
94% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
CS
Borrow rate
0.58%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $0 | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 | $0 |
| Gross margin | — | — | — | — | — |
| R&D | $6.4M | $30.4M | $64.9M | $79.0M | $153.4M |
| Operating income | −$8.7M | −$36.9M | −$74.6M | −$94.3M | −$177.5M |
| EBITDA | −$51.6M | $0 | −$69.3M | −$80.5M | −$166.3M |
| Net income | −$51.6M | −$36.9M | −$69.3M | −$80.5M | −$166.3M |
| Net margin | — | — | — | — | — |
| EPS (diluted) | -40.44 | -1.10 | -2.17 | -2.56 | -4.32 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $125000 | $-4.05 | $-4.18–$-3.76 | 9 |
| 2027 | $44M | $-3.44 | $-3.62–$-3.26 | 6 |
| 2028 | $154M | $-1.41 | $-2.44–$1.10 | 6 |
| 2029 | $318M | $1.14 | $0.54–$1.70 | 4 |
Forward consensus · source: Financial Modeling Prep
ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. The company focuses on advancing its lead product candidate, firmonertinib, for the treatment of epidermal growth factor receptor (EGFR) mutant non-small cell lung cancer (NSCLC), and developing a pipeline of novel therapeutics, including next-generation antibody-drug conjugates such as ARR-217 (MRG007), with an initial focus on solid tumors.
www.arrivent.comNo one on the platform currently holds AVBP.
No tracked institution reports a position in AVBP as of their last filing.
No one on the platform has traded AVBP yet.
| $647M |
| — |
| ERASErasca, Inc. | $18.32 | +0.16% | $5.7B | — |
| IOVAIovance Biotherapeutics, Inc. | $4.16 | -1.19% | $1.5B | — |
Source: Financial Modeling Prep · peers by sector/industry
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
@tonyctl @jenbunn @cubie @Jeremymartin007 @simon58 @EBE_day @ribbey @TraderRapp @Godreal1 @zuby34 got 3 $30P $AVBP because of all the single leg calls. will sell tomorrow if no data.
View on StockTwits ↗@judgeyoung2 @cubie @Jeremymartin007 @simon58 @jenbunn @ribbey @EBE_day @TraderRapp @Godreal1 @zuby34 $AVBP all calls, but no whale multilegs 🤔
View on StockTwits ↗@tonyctl @cubie @Jeremymartin007 @simon58 @jenbunn @ribbey @EBE_day @TraderRapp @Godreal1 @zuby34 any thoughts on $AVBP flow ?
View on StockTwits ↗@zuby34 @ribbey @Jeremymartin007 @Bidzill @cubie @jenbunn @EBE_day @TraderRapp @Godreal1 @tonyctl $AVBP has a lot of activity on the $35C. data is any week now.
View on StockTwits ↗$AVBP just need to keep monitoring volume. it’ll tell us when news is about to drop.
View on StockTwits ↗$AVBP crossing fingers that the data for firmonertinib exceeds what has been presented with sunvozertinib in 1L exon 20 tx.
View on StockTwits ↗$AVBP $1.4B mc Founder-led biotech $XBI Hidden Gem is getting a 'Wait to Buy' recommendation from Trend Edge AI Consult today. Stalking this one for a pullback to the rising 10-week SMA - Pct of all funds at record highs & rising for 8 straight quarters - Short Squeezer underway as Short float % has steadily trended lower over the past 8 months from 34% highs to now 24% TrendEdge.app/asset/AVBP
View on StockTwits ↗$AVBP they wouldn’t let me sell my calls for a fair price yesterday. bastards.
View on StockTwits ↗$AVBP Do you expect efficacy greater, on par with, or worse than WUKONG-28? And why?
View on StockTwits ↗@TraderRapp @Jeremymartin007 @cubie @simon58 @jenbunn @ribbey @EBE_day @Godreal1 @tonyctl @zuby34 $AVBP solid day but they’re not letting me sell for a fair price. will leave my order open.
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.